Rising Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Global Travel And Pathogen Spread Emerges as a Core Driver of the Biological Polymerase Chain Reaction (PCR) Technology Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Biological Polymerase Chain Reaction (PCR) Technology Market Through 2025?
In recent times, the market size of the biological polymerase chain reaction (PCR) technology has seen swift expansion. The predicted growth rate is from $15.06 billion in 2024 to $16.62 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.3%. The surge during the historic phase can be traced back to factors such as the widening scope of forensic DNA analysis, increased funding for academic and clinical research, advancements in agricultural biotechnology, the rising biopharmaceutical industry, and the introduction of genetic testing services.

What's the Projected Size of the Global Biological Polymerase Chain Reaction (PCR) Technology Market by 2029?
Anticipated to experience accelerated expansion in the forthcoming years, the biological polymerase chain reaction (PCR) technology market is projected to surge to $24.31 billion by 2029 with a compound annual growth rate (CAGR) of 10.0%. The projected growth during the forecast period can be ascribed to factors such as the miniaturization and utilization of point-of-care (PoC) devices, liquid biopsy and non-invasive tests, regulatory assistance with accelerated approvals, increased use of reagents and consumables, and substantial funding from both government and private sectors. Key emerging trends during the forecast period encompass microfluidic PCR systems, enhancements to real-time PCR, the development of multiplex PCR technology, integration with next-generation sequencing, and the application of AI and machine learning in PCR analysis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biological-polymerase-chain-reaction-pcr-technology-global-market-report

Top Growth Drivers in the Biological Polymerase Chain Reaction (PCR) Technology Industry: What's Accelerating the Market?
The escalation in the occurrence of infectious diseases is predicted to enhance the expansion of the biological polymerase chain reaction (PCR) technology market. These diseases are brought about by bacteria, viruses, fungi, or parasites. The surge of these infectious diseases is accelerated by greater worldwide travel, enabling the rapid and broad dispersal of pathogens across different regions. The biological polymerase chain reaction (PCR) technology aids in the battle against such diseases through swift and precise pathogen detection which aids in early diagnosis, adequate treatment, and efficient epidemic containment. For example, the World Health Organization, a Swiss-based intergovernmental entity, claimed in November 2023 that in 2022 there were around 249 million malaria cases worldwide, reflecting an escalation of 5 million cases, or a 2% increase, from 2021. Consequently, the soaring rate of infectious diseases is fueling the expansion of the biological polymerase chain reaction (PCR) technology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27223&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Biological Polymerase Chain Reaction (PCR) Technology Market?
Key businesses in the biological polymerase chain reaction (PCR) technology market are focusing their efforts on developing novel strategies, such as microfluidic partitioning, to improve sensitivity, accuracy, and throughput in PCR-based diagnostic and research applications. Microfluidic partitioning is a process that uses microfluidic technology to split a liquid sample into thousands or even millions of tiny, evenly-sized compartments, such as droplets or wells. For example, in August 2022, F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland, introduced the digital PCR system, a potent new platform for combating cancer and other diseases. The digital PCR (dPCR) system is different from traditional PCR technologies and has several unique features. Its most prominent feature is microfluidic partitioning, which splits a sample into thousands or even millions of individual reaction compartments, enabling absolute quantification of target DNA or RNA without the requirement for standard curves. dPCR systems exhibit remarkable sensitivity and precision, making them an excellent choice for identifying low-abundance targets, rare mutations, and minimal residual disease.

What Are the Main Segments in the Biological Polymerase Chain Reaction (PCR) Technology Market?
The biological polymerase chain reaction (PCR) technology market covered in this report is segmented

1) By Product Type: Reagents, Consumables, Software And Services
2) By Technique: Real-Time Polymerase Chain Reaction (PCR), Conventional Polymerase Chain Reaction (PCR), Digital Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (PCR), Hot-Start Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR), Other Polymerase Chain Reaction (PCR) Techniques
3) By Application: Diagnostic Applications, Genotyping, Nucleic Acid Detection, Gene Expression Analysis, Nucleic Acid Synthesis, Genetic Sequencing, Environmental Applications, Standard Validation Or Verification, Other Applications
4) By End User: Hospital Laboratories, Diagnostic Laboratories, Academic And Government Organizations, Pharma-Biotech Companies, Other End Users

Subsegments:
1) By Reagents: DNA Polymerase, DNTPs, Primers And Probes, Buffers And Master Mixes, Enzymes, Nucleic Acid Templates, Additives And Enhancers
2) By Consumables: PCR Tubes, PCR Plates, Sealing Films And Mats, Microplates, Reaction Vessels, Pipette Tips, PCR Strips
3) By Software And Services: PCR Data Analysis Software, Real-Time PCR Analysis Software, Cloud-Based Data Storage Solutions, PCR Workflow Management Tools, Technical Support Services, Calibration And Maintenance Services, Training And Consultation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27223&type=smp

Which Top Companies are Driving Growth in the Biological Polymerase Chain Reaction (PCR) Technology Market?
Major companies operating in the biological polymerase chain reaction (PCR) technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Cepheid Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena GmbH+Co. KG, New England Biolabs Inc., Enzo Biochem Inc., LGC Biosearch Technologies Inc., and Bioline Reagents Ltd.

Which Regions Will Dominate the Biological Polymerase Chain Reaction (PCR) Technology Market Through 2029?
North America was the largest region in the biological polymerase chain reaction (PCR) technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological polymerase chain reaction (PCR) technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27223

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.